Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct‐acting antiviral treatment for HCV

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|1|76-83

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.1, 2018-01, pp. : 76-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct‐acting antivirals

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 1, 2018-01 ,pp. : 72-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

P070: Cytokine patterns of patients with HCV/HBV co‐infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 55-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylaxis of HCV reinfection and direct‐acting antiviral agents during liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 10, 2015-10 ,pp. : 1327-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylaxis of HCV reinfection and direct‐acting antiviral agents during liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 1527-6465, Iss. 10, 2015-10 ,pp. : 1327-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis

By Cooper C.  

QJM: An International Journal of Medicine, Vol. 106, Iss. 2, 2013-02 ,pp. : 153-163

Oxford University Press

Access to resources Recommend Favorite